Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells

Cancer Letters

Volumn 106, Issue 1, 1996, Pages 101-108

  Maia, Raquel C ^a   Wagner, Karen ^b   Cabral, Ramza H ^a   Rumjanek, Vivian M ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Heparin; Multidrug resistance; P glycoprotein; Rhodamine 123

Indexed keywords

HEPARIN; RHODAMINE 123; VERAPAMIL; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; CELL COUNT; CELL STRAIN K 562; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0030598934     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04309-1     Document Type: Article

References (29)

1. [1] Nooter, K. and Herweijer, H. (1991) Multidrug resistance (mdr) genes in human cancer. Br. J. Cancer, 63, 663-669.
2. [2] Juliano, R.L. and Ling, V. (1978) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162.
3. [3] Gottesman, M.M. and Pastan, I. (1988) The multidrug transporter, a double-edged sword. J. Biol. Chem., 265, 12163-12166.
4. [4] Neyfalkh, A.A. (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res., 174, 168-176.
5. [5] Tsuruo, T., Iida, H., Nojir, M., Tsukagoshi, S. and Sakurai, Y. (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res., 43, 2905-2910.
6. [6] Tsuruo, T., Iida, H., Kitani, Y., Yokota, K., Tsukaggoshi, S. and Sukurai, Y. (1984) Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistance tumor cells. Cancer Res., 44, 4303-4307.
7. [7] Ozols, R.F., Cunnion, R.E., Klecker, R.W., Hamilton, T.C., Ostchega, Y., Parillo, J.E. et al. (1987) Verapamil and adriamycin in the treatment of drug resistant ovarian cancer patients. J. Clin. Oncol., 5, 641-647.
8. [8] Ganapathi, R., Schmidt, H., Grabowski, D., Melia, M. and Tathiff, N. (1988) Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance. Br. J. Cancer, 58, 335-340.
9. [9] Kirk, J., Syed, S.K., Harris, A.L., Jarman, M., Roufogalis, B.D., Stratford, I.J. and Carmichael, J. (1994) Reversal of P-glycoprotein-mediated multidrug resistance by pure antiestrogens and novel tamoxifen derivates. Biochim. Pharmacol., 48, 277-285.
10. [10] Twentyman, P.R., Fox, N.E. and White, D.J.C. (1987) Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Br. J. Cancer, 56, 55-57.
11. [11] Keller, R.P., Alternatt, H.J., Nooter, K., Poschmann, G., Lairssue, J.A., Bollinger, P. and Hiestand, P.C. (1992) SDZ PSC833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukaemia. Int. J. Cancer, 50, 593-597.
12. [12] Ford, J.M. and Hair, Wn. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155-199.
13. [13] Lehnert, M., Dalton, W.S., Roe, D., Emerson, S. and Salmon, S. (1991) Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood, 77, 348-354.
14. [14] Tyrrel, D.J., Kilfeather, S. and Page, C.P. (1995) Therapeutic uses of heparin beyond its traditional roles as an anticoagulant. Trends Pharmacol. Sci., 16, 198-204.
15. [15] Coombe, D.R. (1987) Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int. J. Cancer, 39, 82-88.
16. [16] Putney, J.W. and Bird, G.S.T.J. (1993) The signal for capacitivite calcium entry. Cell, 75, 199-201.
17. 2+ transport ATPases by heparin. J. Biol. Chem., 269, 14525-14529.
18. [18] Koch, G., Smith, M., Twentyman, P. and Wright, K. (1986) Identification of a novel calcium-binding protein (CP22) in multidrug-resistant murine and hamster cells. FEBS Lett., 195, 275-279.
19. [19] Mosmann, T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods, 65, 56-63.
20. [20] Klimecki, W.T., Futscher, B.W., Grogan, T.M. and Dalton, W.S. (1994) P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood, 83, 2451-2458.
21. [21] Bradbury, M.G. and Parish, C.R. (1988) Receptors on lymphocytes for endogenous splenic glycosaminoglycans. Immunology, 66, 546-553.
22. [22] Castellot, J.J., Wong, K., Herman, B., Hoover, R.L., Albertini, D.F., Wright, T.C., Caleb, B.L. and Karnofsky, M. (1985) Binding and internalization of heparin by vascular smooth muscle cells. J. Cell. Physiol., 124, 13-20.
23. [23] Biswas, C. (1988) Heparin and heparan-sulphate binding sites on B16 melanoma cells. J. Cell Physiol., 136, 147-153.
24. [24] Redini, F., Moczar, E., Antoine, E. and Poupon, M.F. (1989) Binding and internalization of exogenous glycosaminoglicans in weakly and highly metastatic rhabdomyosarcoma cells. Biochim. Biophys. Acta, 991, 359-366.
25. [25] Bertolesi, G.E., de Cidre, L.L., de Lusting, E.S. and Eiján, A.M. (1995) Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition. Cancer Lett., 90, 123-131.
26. [26] Ottlinger, M.E., Pukac, L.A. and Karnovsky, M.J. (1993) Heparin inhibits mitogenic activated protein Kinase activation in intact rat vascular smooth muscle cells. J. Biol. Chem., 268, 19173-19176.
27. [27] Dupuy, E., Rohrlich, P.S. and Tobelem, G. (1988) Heparin stimulates fibroblastics growth induced by platelet derived growth factor. Cell Biol. Int. Rep., 12, 17-28.
28. [28] Roberts, R., Gallagher, J., Spoocer, E., Allan, J.D., Bloomfield, F. and Dexter, T.M. (1988) Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature, 332, 376-378.
29. [29] Halper, J. and Carter, B.F. (1989) Modulation of growth of human carcinoma SW-13 cells by heparin and growth factors. J. Cell Physiol., 141, 16-23.